{"disease":{"id":"microvascular-rarefaction","name":"microvascular rarefaction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05464849","title":"Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension","phase":"","overall_status":"COMPLETED","enrollment_count":111,"lead_sponsor_name":"National Institute of Cardiology, Laranjeiras, Brazil","has_results":false},{"nct_id":"NCT05728047","title":"Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"National Institute of Cardiology, Laranjeiras, Brazil","has_results":false},{"nct_id":"NCT04406545","title":"Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"National Institute of Cardiology, Laranjeiras, Brazil","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}